IVD Test Reagent/Kits, Molecular Assay, Infection, Bacteria, Brucella abortus, DNA

Definition : Molecular assay reagents intended to identify Brucella abortus, a coccobacillus bacterium, by detecting specific genetic information of the deoxyribonucleic acid (DNA) of the target bacteria. These bacteria are an etiologic agent of brucellosis, a disease characterized by intermittent (i.e., undulant) fever.

Entry Terms : "Brucella abortus Detection/Identification Reagents" , "Cyprus Fever Diagnostic Reagents" , "Relapsing Fever Diagnostic Reagents" , "Mediterranean Fever Diagnostic Reagents" , "Malta Fever Diagnostic Reagents" , "Undulant Fever Diagnostic Reagents" , "Brucellosis Diagnostic Reagents" , "Bang's Disease Diagnostic Reagents" , "Brucella Species Detection/Identification Reagents" , "Reagents, Molecular Assay, Infection, Bacteria, Brucella abortus, DNA"

UMDC code : 21488

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).


Company Type: Parent

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

Immunostics Inc

Company Type: Parent

Clinical diagnostics is a dynamic discipline thus evolution and change are constant. The firms that service the medical field must be efficient, flexible and most importantly cost-effective. Immunostics is keenly aware of these obligations as well as to the commitments that you, the health care professional, make to your patients every day. As we complete our 26th year of operation, Immunostics realizes that your input regarding product performance, technical assistance and customer service is of the utmost importance. Immunostics offers a broad portfolio of performance-driven diagnostics solutions that provide more effective ways to assist in the diagnosis of disease. We also have the proud distinction of having been chosen as the supplier of products to support the United Kingdom's colorectal cancer screening program for the past 12 years, and it continues to support additional fecal occult blood screening programs throughout the world

ZeptoMetrix Corp

Company Type: Parent

ZeptoMetrix is a privately held company formed in 1999 to serve the diagnostic and pharmaceutical research products industries. In 2003, the company acquired the BioClinical Partners division of Impath Corporation and a highly complementary and successful partnership was formed.

1-3 of 3 Match(es).


Sign Up for Free e-newsletters

Medical Product Guide OBG Management Product Zone